Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group.
Related posts
-
Villa Park police warn people to stay away from North Avenue
In the wake of a high-speed collision and a takeover in the area, Villa Park police... -
Palatine says farewell to man who helped village chart debt-free path
Palatine said goodbye this month to Finance Director Paul Mehring, who retired Friday after 28 years... -
Bears lose ninth straight: What worked, what didn’t?
What worked and what didn’t for the Bears in Sunday’s 34-17 loss to the Lions?